Improving decisions about the funding of high cost cancer medicines in Australia

在这个项目中，我们将解决一个紧迫的政策问题：那些资助癌症药物的人如何应对他们面临的日益加剧的经济和伦理挑战？具体而言，我们将探索如何使资金决策在不同利益相关者（包括患者、公众、政府和制药公司）眼中更公平、更合法。我们还将考虑如何将这些准则推广到其他药物的资助。

In this project, we will address the pressing policy question: How can those funding cancer medicines manage the intensifying economic and ethical challenges that they face? Specifically, we will explore ways of making funding decisions fairer and more legitimate in the eyes of different stakeholders, including patients, the general public, governments and pharmaceutical companies. We will also consider ways in which these guidelines might be generalised to the funding of other medicines.